FNCH · Categories · Form 4

FNCH - SEC Form 4 insider transactions

Finch Therapeutics Group Inc. (FNCH) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for FNCH

• 685d
  Director Smisek Jeffery A gifted 767 shares, decreasing direct ownership by 2% to 17,870 units (SEC Form 4)

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 702d
  Smisek Jeffery A gifted 3,750 shares (SEC Form 4)

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 758d
  Smisek Jeffery A sold $21,246 worth of shares (8,242 units at $2.58), closing all direct ownership in the company (SEC Form 4)

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 881d
  Smisek Jeffery A sold $5,351 worth of shares (1,470 units at $3.64), decreasing direct ownership by 18% to 6,642 units (SEC Form 4)

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1038d
  SEC Form 4 filed by Blischak Matthew P. (Amendment)

  4/A - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1052d
  SEC Form 4 filed by Blischak Matthew P.

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1052d
  SEC Form 4 filed by Lange Christian H.

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1052d
  SEC Form 4 filed by Smisek Jeffery A

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1052d
  SEC Form 4 filed by Haft Nicholas

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1052d
  SEC Form 4 filed by Graf Susan E

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1052d
  SEC Form 4 filed by Ferrante Domenic J

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1052d
  SEC Form 4 filed by Shumway Chris

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1158d
  SEC Form 4: Blaustein Marc sold $1,755 worth of shares (4,619 units at $0.38), decreasing direct ownership by 14% to 27,995 units (tax withholding)

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1279d
  SEC Form 4: Blaustein Marc sold $5,054 worth of shares (3,636 units at $1.39), decreasing direct ownership by 10% to 32,614 units (for tax liability)

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1279d
  SEC Form 4: Vittiglio Joseph sold $5,054 worth of shares (3,636 units at $1.39), decreasing direct ownership by 10% to 31,364 units to cover withholding tax

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1411d
  SEC Form 4 filed by Shumway Chris

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1411d
  SEC Form 4: Blaustein Marc was granted 35,000 shares, increasing direct ownership by 2,800% to 36,250 units

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1411d
  SEC Form 4 filed by Lange Christian H.

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1411d
  SEC Form 4: Vittiglio Joseph was granted 35,000 shares

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1411d
  SEC Form 4 filed by Ferrante Domenic J

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1411d
  SEC Form 4 filed by Hamood Samuel A

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1411d
  SEC Form 4 filed by Graf Susan E

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1411d
  SEC Form 4 filed by Viney Joanne L.

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1411d
  SEC Form 4 filed by Smisek Jeffery A

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1411d
  SEC Form 4 filed by Haft Nicholas

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1518d
  SEC Form 4 filed by Blaustein Marc

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1518d
  SEC Form 4 filed by Perry Gregory D

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1518d
  SEC Form 4 filed by Vittiglio Joseph

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1586d
  SEC Form 4: Haft Nicholas bought $649,993 worth of shares (63,850 units at $10.18)

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1587d
  SEC Form 4 filed by Vittiglio Joseph

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1664d
  SEC Form 4 filed by Hamood Samuel A

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1689d
  SEC Form 4 filed by Blaustein Marc

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1808d
  SEC Form 4 filed by Viney Joanne L.

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1825d
  SEC Form 4 filed by Graf Susan E

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1858d
  SEC Form 4: Llc Investor Crestovo converted 11,906,147 units into Common Stock and bought $12,499,998 worth of Common Stock (735,294 units at $17.00)

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1858d
  SEC Form 4: Nicholas Haft converted 3,110,706 units into Common Stock and bought $14,999,967 worth of Common Stock (882,351 units at $17.00)

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1858d
  SEC Form 4: J Domenic Ferrante converted 533,254 units into Common Stock and bought $1,749,997 worth of Common Stock (102,941 units at $17.00)

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)
• 1858d
  SEC Form 4: A Jeffery Smisek converted 1,606,306 units into Common Stock and bought $1,499,995 worth of Common Stock (88,235 units at $17.00)

  4 - Finch Therapeutics Group, Inc. (0001733257) (Issuer)

Other FNCH categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends